when fda approve intellia therapeutics' lonvo-z
Before 2028
when fda approve intellia therapeutics' lonvo-z. Best Yes near 69¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 69¢ · Best No: 41¢ · 1 platform
- Kalshi: Yes 69¢ / No 41¢
LIVE
Before 2028
Volume
$429
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Jan 1, 2028
~564 days left
Category
Culture
Yes
69¢
Kalshi
No
41¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jan 1, 2028, then the market resolves to Yes.
Market Details
ResolutionResolves Jan 1, 2028
Time Left564 days
Status● Active
CategoryCulture
Yes
69¢
Kalshi
Payout 1.4x
No
41¢
Kalshi
Payout 2.4x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In